Martin Rudwaleit

29PUBLICATIONS
76CO-AUTHORS
Rheumatology and arthritisAllergyAutoimmunitySocio-economic developmentDiagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 17, 2026
Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the Phase 3 BE MOBILE rials.

|Jun 02, 2026
Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials.

|Dec 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials.

John D Reveille, Martin Rudwaleit, Proton Rahman

|Nov 28, 2025
Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies.

Helena Marzo-Ortega, Victoria Navarro-Compan, Maureen Dubreuil

|Sep 24, 2025
Longitudinal association of early axial spondyloarthritis status at the time of diagnosis with disease activity over time: 10-year results from the GESPIC cohort.

David Kiefer, Imke Redeker, Murat Torgutalp

|Apr 09, 2025
BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.

Martin Rudwaleit, Victoria Navarro-Compán, Hagen Russ

Pageof 5

Frequent Collaborators

13 joint publications

Victoria Navarro-Compán

11 joint publications

Denis Poddubnyy

10 joint publications

Xenofon Baraliakos

7 joint publications

Helena Marzo-Ortega